<DOC>
	<DOC>NCT02269228</DOC>
	<brief_summary>To investigate the occurrence of dipyridamole associated headaches in healthy subjects using a titration scheme or not</brief_summary>
	<brief_title>Tolerability of Asasantin in Healthy Female and Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Aspirin, Dipyridamole Drug Combination</mesh_term>
	<criteria>All participants in the study should be healthy females/males, range from 18 to 55 years of age and be within a Broca Index of ≥ 20 % and ≤ + 20 % Prior to admission to the study all subjects will have given, in accordance with good clinical practice (GCP) and the local legislation, their written informed consent. Subjects will be excluded from the study if the results of the medical examination (including blood pressure, pulse rate and ECG) deviating from normal and are of clinical relevance Subjects with known gastrointestinal, hepatic, renal, respiratory, cardiovascular, metabolic, immunological or hormonal disorders Subjects with diseases of the central nervous system (such as epilepsy) or with psychiatric disorders or neurological disorders Subjects with known history of orthostatic hypotension, fainting spells or blackouts Subjects with chronic or relevant acute infections Subjects with history of allergy/hypersensitivity (including drug allergy) which is deemed relevant to the trial as judged by the investigator Subjects who have taken a drug with a long halflife (&gt; 24 hours) (≤ 1 month prior to administration or during the trial) Subjects who received any other drugs which might influence the results of the trial (≤ 10 days prior to administration or during the trial) Subjects who have participated in another study with an investigational drug (≤ 1 month prior to administration or during the trial) Subjects who smoke more than 15 cigarettes or 4 cigars or 4 pipes/day Subjects who are not able to refrain from excessive consumption of methylxanthine containing drinks or food Subjects who drink more than 60 g of alcohol per day Subjects who are dependent on drugs Subjects who have donated blood (&gt; 400 ml) (≤ 4 weeks prior to administration or during the trial) Subjects who have participated in excessive physical activities (≤ 5 days prior to administration or during the trial) For female subjects: Pregnancy Positive pregnancy test No adequate contraception (acceptable: e.g. sterilisation, intrauterine devices (IUD), oral contraceptives, condoms) Inability to maintain this adequate contraception during the whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>